C
MRVI icon

Covestor’s Maravai LifeSciences MRVI Stock Holding History

Covestor’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Sell
1,664
-3,522
-68% -$11.9K ﹤0.01% 1809
2025
Q4 		$17K Hold
5,186
– – 0.01% 1355
2025
Q3 		$15K Sell
5,186
-9
-0.2% -$23 0.01% 1401
2025
Q2 		$13K Buy
5,195
+4,169
+406% +$8.76K 0.01% 1418
2025
Q1 		$2K Buy
1,026
+4
+0.4% +$16 ﹤0.01% 1863
2024
Q4 		$6K Buy
1,022
+1
+0.1% +$6 ﹤0.01% 1696
2024
Q3 		$8K Buy
1,021
+1
+0.1% +$9 0.01% 1662
2024
Q2 		$7K Buy
1,020
+3
+0.3% +$26 ﹤0.01% 1720
2024
Q1 		$9K Sell
1,017
-48
-5% -$325 0.01% 1656
2023
Q4 		$7K Buy
1,065
+564
+113% +$3.64K ﹤0.01% 1726
2023
Q3 		$5K Sell
501
-586
-54% -$6.43K ﹤0.01% 1721
2023
Q2 		$14K Buy
1,087
+622
+134% +$8.4K 0.01% 1286
2023
Q1 		$7K Buy
465
+1
+0.2% +$14 0.01% 1473
2022
Q4 		$7K Buy
464
+194
+72% +$3.06K 0.01% 1476
2022
Q3 		$7K Sell
270
-3,523
-93% -$88.4K 0.01% 1404
2022
Q2 		$108K Buy
3,793
+3,319
+700% +$105K 0.09% 375
2022
Q1 		$17K Buy
474
+83
+21% +$2.78K 0.01% 1113
2021
Q4 		$16K Buy
+391
New +$15.8K 0.02% 909

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Covestor's MRVI Position: Q1 2026 in Review

Covestor reduced its Maravai LifeSciences (MRVI) stake by 68% in Q1 2026, selling an estimated $11.9K and leaving 1,664 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Covestor first reported a position in MRVI in Q4 2021 and has held it in 18 quarters since. The position peaked at $108K in Q2 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Covestor held 1,664 shares of Maravai LifeSciences worth $5K as of Q1 2026.
  • Covestor sold 3,522 Maravai LifeSciences shares in Q1 2026, an estimated $11.9K.
  • Maravai LifeSciences made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #1809 holding.
  • Covestor first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Maravai LifeSciences position peaked at $108K in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.